Literature DB >> 12445307

Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies.

A Petrone1, T Battelino, C Krzisnik, T Bugawan, H Erlich, U Di Mario, P Pozzilli, R Buzzetti.   

Abstract

The incidence of type 1 diabetes (T1DM) seems to depend in part on the population frequencies of susceptible and protective HLA haplotypes. The present study aimed to (i): characterize the genetic susceptibility to T1DM in the Slovenian population, (ii) test the general hypothesis that T1DM incidence is related to the frequencies of susceptible/protective haplotypes, (iii) compare allele, haplotype and genotype frequencies in Slovenians and Italians that represent two white populations with a similar incidence of T1DM (7.9/100,000/year and 8.1/100,000/year, respectively). The haplotype found most frequently among Slovenian T1DM patients was DRB1*0301-DQA1*0501-DQB1*0201 (53%). The DR4-DQA1*0301-DQB1*0302 haplotypes conferring susceptibility to T1DM were those bearing DRB1*0401 (OR = 12), DRB1*0404 (OR = 4.7) and DRB1*0402 (OR = 4.5). Negative associations with the disease were found for the following haplotypes: DRB1*1501-DQA1*0102-DQB1*0602, DRB1*1301-DQA1*0102-DQB1*0603, DRB1*1101/1104-DQA1*0501-DQB1*0301, and DRB1*1401-DQA1*0101-DQB1*0503. Our findings indicate that the low frequencies of susceptible genotypes, in particular, DR3-DQA1*0501-DQB1*0201/DR4-DQA1*0301-DQB1*0302, together with a high frequency of protective haplotypes, could in part explain the low incidence of T1DM in the Slovenian population. The combined frequencies of susceptible genotypes were similar in the two populations (Slovenia = 19.2%, Italy = 17.6%), and the 95% confidence limits of the OR values for each genotype in the two populations overlapped, indicating no significant differences between the values. We conclude that the similar incidences of T1DM in Italian and Slovenian populations are in part a reflection of similar frequencies of HLA susceptible/protective haplotypes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12445307     DOI: 10.1034/j.1399-0039.2002.600306.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  10 in total

1.  Age-dependent loss of tolerance to an immunodominant epitope of glutamic acid decarboxylase in diabetic-prone RIP-B7/DR4 mice.

Authors:  John A Gebe; Kellee A Unrath; Ben A Falk; Kouichi Ito; Li Wen; Terri L Daniels; Ake Lernmark; Gerald T Nepom
Journal:  Clin Immunol       Date:  2006-09-18       Impact factor: 3.969

Review 2.  HLA and disease.

Authors:  Yogita Ghodke; Kalpana Joshi; Arvind Chopra; Bhushan Patwardhan
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  Human leukocyte antigen-A, -B, -C, -DRB1 allele and haplotype frequencies in Americans originating from southern Europe: contrasting patterns of population differentiation between Italian and Spanish Americans.

Authors:  Steven J Mack; Bin Tu; Ruyan Yang; Carly Masaberg; Jennifer Ng; Carolyn Katovich Hurley
Journal:  Hum Immunol       Date:  2010-10-23       Impact factor: 2.850

4.  Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies.

Authors:  Owen D Solberg; Steven J Mack; Alex K Lancaster; Richard M Single; Yingssu Tsai; Alicia Sanchez-Mazas; Glenys Thomson
Journal:  Hum Immunol       Date:  2008-06-09       Impact factor: 2.850

Review 5.  Genetics of the HLA region in the prediction of type 1 diabetes.

Authors:  Janelle A Noble; Ana M Valdes
Journal:  Curr Diab Rep       Date:  2011-12       Impact factor: 4.810

6.  HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus.

Authors:  R Strollo; P Rizzo; M Spoletini; R Landy; C Hughes; F Ponchel; N Napoli; A Palermo; R Buzzetti; P Pozzilli; A Nissim
Journal:  Diabetologia       Date:  2012-11-19       Impact factor: 10.122

7.  Determination of High-Resolution HLA-DQB1 Suballeles and IL-17 Polymorphisms in Turkish Pediatric Patients.

Authors:  Aslı Eldem; Tülay Kılıçaslan Ayna; Maşallah Baran; Mustafa Soyöz; İbrahim Pirim
Journal:  J Pediatr Genet       Date:  2021-02-11

8.  HLA-A, -B, -C, and -DRB1 allele and haplotype frequencies distinguish Eastern European Americans from the general European American population.

Authors:  S J Mack; B Tu; A Lazaro; R Yang; A K Lancaster; K Cao; J Ng; C K Hurley
Journal:  Tissue Antigens       Date:  2008-10-24

9.  C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory study.

Authors:  Raffaella Buzzetti; Simona Cernea; Antonio Petrone; Marco Capizzi; Marialuisa Spoletini; Simona Zampetti; Chiara Guglielmi; Chiara Venditti; Paolo Pozzilli
Journal:  Diabetes       Date:  2011-09-06       Impact factor: 9.461

10.  Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history.

Authors:  James A Traherne; Roger Horton; Anne N Roberts; Marcos M Miretti; Matthew E Hurles; C Andrew Stewart; Jennifer L Ashurst; Alexey M Atrazhev; Penny Coggill; Sophie Palmer; Jeff Almeida; Sarah Sims; Laurens G Wilming; Jane Rogers; Pieter J de Jong; Mary Carrington; John F Elliott; Stephen Sawcer; John A Todd; John Trowsdale; Stephan Beck
Journal:  PLoS Genet       Date:  2006-01-27       Impact factor: 5.917

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.